Posted by SLS on August 24, 2022, at 11:11:16
Hi, All.
The FDA approved Axsome (dextromethorphan + bupropion) on August 19.
"On 19 August, the US Food and Drug Administration (FDA ) approved Axsome Therapeutics (US) Auvelity (dextromethorphan + bupropion) for the treatment of major depressive disorder (MDD) in adults. Auvelity is the first orally administered product with a novel mechanism of action (MOA) to enter the MDD market in more than 60 years. The dextromethorphan component targets the N-methyl D-aspartate (NMDA) receptor and the sigma-1 receptor in the brain, while the bupropion component acts to increase levels of dextromethorphan in the blood.""The drug, Auvelity, is a new class of treatment that reduces the symptoms of depression as early as one week, giving it a potential edge over older antidepressants, which can take up to six weeks to show effect."
https://www.clinicaltrialsarena.com/comment/fda-axsome-therapeutics/
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.The only thing necessary for the triumph of evil is that good men do nothing.
poster:SLS
thread:1120470
URL: http://www.dr-bob.org/babble/20220530/msgs/1120470.html